Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF Enriched Fat Grafting for Chronic Wounds
NCT03882983Phase 1Unknown
- Sponsor
- Antria, Inc.
- Start
- Sep 2017
- Primary completion
- Dec 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous adipose stromal vascular fraction in Chronic wound, sponsored by Antria, Inc. Primary endpoint: Bates-Jensen Wound Assessment at 1 year. Status: unknown.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
Chronic wound
Beyond the preview
Go deeper on NCT03882983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882983.